Nuritas Gains Momentum with $42 Million Series C Funding
Deal News | Jan 14, 2025 | Grosvenor Group Ltd
Nuritas, a leader in peptide discovery and development, has secured a significant $42 million in a Series C funding round, with contributions from Grosvenor Food & AgTech. The funds will be used to advance Nuritas's mission of enhancing consumer health by improving and expanding their bioactive peptide offerings. CEO Dr. Nora Khaldi emphasizes the company's commitment to transforming the discovery of health-promoting ingredients through their advanced AI and genomics platform. With a robust peptide knowledge base and strategic collaborations, including with industry giants like Nestlé and Mars, Nuritas is set to expand its global influence across diverse markets including functional foods, dietary supplements, and cosmetics.
Sectors
- Biotechnology
- Food Technology
- Investment
Geography
- Ireland – Nuritas is based in Dublin, Ireland, and plays a central role in the article.
Industry
- Biotechnology – The article focuses on Nuritas's peptide discovery and development, which is a crucial aspect of the biotechnology sector.
- Food Technology – Nuritas's peptides are used in functional foods and supplements, highlighting the intersection of biotechnology and food technology.
- Investment – Grosvenor's involvement in the funding round places the article within the context of financial investments in innovative health and technology sectors.
Financials
- $42 million – The total amount raised by Nuritas in its Series C funding round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Nuritas | Target Company | Company | A pioneering company in peptide discovery and development, leveraging AI and genomics to create health-enhancing products. |
| Grosvenor Group Ltd. | Investor | Company | A private equity firm that participated in the $42 million Series C funding round for Nuritas. |
| Dr. Nora Khaldi | CEO of Nuritas | Person | Founder and CEO of Nuritas, spearheading its mission to revolutionize ingredient discovery. |
| Givaudan | Partner | Company | A partner company working with Nuritas on peptide applications. |
| Nestlé | Partner | Company | Partnering with Nuritas in utilizing peptides for health-promoting products. |
| Mars | Partner | Company | A global consumer goods company collaborating with Nuritas on peptide-based advancements. |
| Sumitomo Corporation | Partner | Company | Partner of Nuritas, focusing on exploring peptides for functional and medical foods. |